SWK Holdings' Subsidiary, Enteris BioPharma, Receives $10 Million Milestone Payment from Cara ...

Retrieved on: 2021-06-11 11:26:15

Tags for this article:

Click the tags to see associated articles and topics

SWK Holdings' Subsidiary, Enteris BioPharma, Receives $10 Million Milestone Payment from Cara .... View article details on hiswai:

Excerpt

SWK also owns Enteris BioPharma, whose Peptelligence® and ProPerma™ drug delivery technologies create oral formulations of peptide-based and ...

Article found on: www.inforney.com